Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A Perspective

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Non-small cell lung cancer (NSCLC) is the most common type of lung cancer globally.
• Estrogen exposure and the presence of estrogen receptors (ERs) in lung tissues suggest a role for estrogens in NSCLC development and progression.
• Women, especially premenopausal individuals, exhibit a higher risk for lung adenocarcinoma, a subtype of NSCLC.

Purpose of the Study:

• To elucidate the role of estrogens and their associated receptors (ERs, GPERs, EGFRs, ERRs) in NSCLC pathogenesis.
• To investigate the cell signaling pathways activated by estrogens in NSCLC.
• To review the efficacy of anti-estrogen therapies in managing NSCLC.

Main Methods:

• Review of current literature on estrogen signaling in NSCLC.
• Analysis of epidemiological data regarding sex-based differences in NSCLC risk.
• Examination of molecular mechanisms involving ERs, GPERs, EGFRs, and ERRs in NSCLC cell signaling.

Main Results:

• Estrogen-ER/GPER/EGFR/ERR signaling pathways significantly influence NSCLC cell proliferation, survival, and apoptosis.
• Premenopausal women are at increased risk due to higher endogenous estrogen levels.
• Epidemiological studies confirm a higher incidence of lung adenocarcinoma in women, independent of smoking.

Conclusions:

• Estrogen signaling pathways are critical regulators of NSCLC progression.
• Understanding these pathways provides insights into targeted therapeutic strategies.
• Anti-estrogen therapies demonstrate potential efficacy in treating NSCLC.